IL7 and lymphopenia: IL-7 immunotherapy is currently being evaluated as a treatment to reverse the lymphopenia in COVID-19 patients and was shown to restore lymphocyte count in critically ill COVID-19 patients without worsening pulmonary injury and inflammation27.